My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 224

    1.

    Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study.

    Brunner EJ, Shipley MJ, Witte DR, Fuller JH, Marmot MG.

    Diabetes Care. 2006 Jan;29(1):26-31.PMID: 16373891 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Postchallenge hyperglycemia and mortality in a national sample of U.S. adults.

    Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL.

    Diabetes Care. 2001 Aug;24(8):1397-402.PMID: 11473076 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80.

    Kadowaki S, Okamura T, Hozawa A, Kadowaki T, Kadota A, Murakami Y, Nakamura K, Saitoh S, Nakamura Y, Hayakawa T, Kita Y, Okayama A, Ueshima H; NIPPON DATA Research Group.

    Diabetologia. 2008 Apr;51(4):575-82. Epub 2008 Jan 16.PMID: 18197396 [PubMed - indexed for MEDLINE]Related articles

    4.

    Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study.

    Adlerberth AM, Rosengren A, Wilhelmsen L.

    Diabetes Care. 1998 Apr;21(4):539-45.PMID: 9571339 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Relationship of postload plasma glucose to mortality with 19-yr follow-up. Comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas Company Study.

    Vaccaro O, Ruth KJ, Stamler J.

    Diabetes Care. 1992 Oct;15(10):1328-34.PMID: 1425098 [PubMed - indexed for MEDLINE]Related articles

    6.

    Midlife body mass index and hospitalization and mortality in older age.

    Yan LL, Daviglus ML, Liu K, Stamler J, Wang R, Pirzada A, Garside DB, Dyer AR, Van Horn L, Liao Y, Fries JF, Greenland P.

    JAMA. 2006 Jan 11;295(2):190-8.PMID: 16403931 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study.

    Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, Forhan A, Eschwège E.

    Diabetes Care. 1998 Mar;21(3):360-7.PMID: 9540016 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

    Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwège E.

    Diabetologia. 1991 May;34(5):356-61.PMID: 1864491 [PubMed - indexed for MEDLINE]Related articles

    9.

    Is there a glycemic threshold for mortality risk?

    Balkau B, Bertrais S, Ducimetiere P, Eschwege E.

    Diabetes Care. 1999 May;22(5):696-9.PMID: 10332668 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

    Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A.

    JAMA. 2005 Oct 12;294(14):1799-809. Erratum in: JAMA. 2005 Dec 14;294(22):2848. PMID: 16219884 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Risk factors and coronary morbimortality in a Mediterranean industrial cohort over 28 years of follow-up. The Manresa Study]

    Tomàs Abadal L, Varas Lorenzo C, Pérez I, Puig T, Balaguer Vintró I.

    Rev Esp Cardiol. 2001 Oct;54(10):1146-54. Spanish. PMID: 11591294 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.

    Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H.

    Br Med J (Clin Res Ed). 1983 Sep 24;287(6396):867-70.PMID: 6412862 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

    Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H.

    Lancet. 1980 Jun 28;1(8183):1373-6.PMID: 6104171 [PubMed - indexed for MEDLINE]Related articles

    14.

    Physical activity and cause-specific mortality in men with Type 2 diabetes/impaired glucose tolerance: evidence from the Whitehall study.

    Batty GD, Shipley MJ, Marmot M, Smith GD.

    Diabet Med. 2002 Jul;19(7):580-8.PMID: 12099962 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program.

    Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Yano K, Curb JD.

    Diabetes Care. 1999 Aug;22(8):1262-5.PMID: 10480768 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males. The Paris Prospective Study.

    Fontbonne A, Tchobroutsky G, Eschwege E, Richards JL, Claude JR, Rosselin GE.

    Int J Obes. 1988;12(6):557-65.PMID: 3069769 [PubMed - indexed for MEDLINE]Related articles

    17.

    Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.

    Pyöräla K.

    Diabetes Care. 1979 Mar-Apr;2(2):131-41.PMID: 520116 [PubMed - indexed for MEDLINE]Related articles

    18.

    Magnitude and causes of socioeconomic differentials in mortality: further evidence from the Whitehall Study.

    Smith GD, Shipley MJ, Rose G.

    J Epidemiol Community Health. 1990 Dec;44(4):265-70.PMID: 2277246 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Impact of socioeconomic status on coronary mortality in people with symptoms, electrocardiographic abnormalities, both or neither: the original Whitehall study 25 year follow up.

    Hemingway H, Shipley M, Macfarlane P, Marmot M.

    J Epidemiol Community Health. 2000 Jul;54(7):510-6.PMID: 10846193 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey.

    Whiteley L, Padmanabhan S, Hole D, Isles C.

    Diabetes Care. 2005 Jul;28(7):1588-93.PMID: 15983305 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity